School of Molecular and Biomedical Science, University of Adelaide, North Tce, Adelaide, South Australia 5005, Australia.
Appl Microbiol Biotechnol. 2012 Feb;93(3):983-92. doi: 10.1007/s00253-011-3796-z. Epub 2011 Dec 20.
Acetyl-CoA carboxylase (ACC) catalyses the first committed step in fatty acid biosynthesis: a metabolic pathway required for several important biological processes including the synthesis and maintenance of cellular membranes. ACC employs a covalently attached biotin moiety to bind a carboxyl anion and then transfer it to acetyl-CoA, yielding malonyl-CoA. These activities occur at two different subsites: the biotin carboxylase (BC) and carboxyltransferase (CT). Structural biology, together with small molecule inhibitor studies, has provided new insights into the molecular mechanisms that govern ACC catalysis, specifically the BC and CT subunits. Here, we review these recent findings and highlight key differences between the bacterial and eukaryotic isozymes with a view to establish those features that provide an opportunity for selective inhibition. Especially important are examples of highly selective small molecule inhibitors capable of differentiating between ACCs from different phyla. The implications for early stage antibiotic discovery projects, stemming from these studies, are discussed.
乙酰辅酶 A 羧化酶(ACC)催化脂肪酸生物合成的第一步:这是一条代谢途径,对于包括细胞膜的合成和维持在内的几个重要生物过程都是必需的。ACC 采用共价连接的生物素部分来结合一个羧基阴离子,然后将其转移到乙酰辅酶 A 上,生成丙二酰辅酶 A。这些活性发生在两个不同的亚基部位:生物素羧化酶(BC)和羧基转移酶(CT)。结构生物学和小分子抑制剂研究为 ACC 催化的分子机制提供了新的见解,特别是 BC 和 CT 亚基。在这里,我们回顾了这些最新发现,并强调了细菌和真核同工酶之间的关键差异,以期确定那些提供选择性抑制机会的特征。特别重要的是那些能够区分不同门的 ACC 的高度选择性小分子抑制剂的例子。从这些研究中得出的对于早期抗生素发现项目的意义也进行了讨论。